392 related articles for article (PubMed ID: 7533221)
1. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
2. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
[TBL] [Abstract][Full Text] [Related]
4. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
5. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
[TBL] [Abstract][Full Text] [Related]
6. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
Prichard BN; Owens CW; Graham BR
J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
[TBL] [Abstract][Full Text] [Related]
10. Low dose of moxonidine within the rostral ventrolateral medulla improves the baroreflex sensitivity control of sympathetic activity in hypertensive rat.
Wang JL; Wang L; Wu ZT; Yuan WJ; Su DF; Ni X; Yan JJ; Wang WZ
Acta Pharmacol Sin; 2009 Dec; 30(12):1594-600. PubMed ID: 19960005
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
[TBL] [Abstract][Full Text] [Related]
12. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
[TBL] [Abstract][Full Text] [Related]
13. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
Ernsberger P; Friedman JE; Koletsky RJ
J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
15. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs.
Li G; Wang X; Abdel-Rahman AA
J Cardiovasc Pharmacol; 2005 Jul; 46(1):52-62. PubMed ID: 15965355
[TBL] [Abstract][Full Text] [Related]
16. Moxonidine: a new antiadrenergic antihypertensive agent.
Prichard BN; Graham BR; Owens CW
J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
[TBL] [Abstract][Full Text] [Related]
17. Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats.
Wang YK; Yu Q; Tan X; Wu ZT; Zhang RW; Yang YH; Yuan WJ; Hu QK; Wang WZ
J Hypertens; 2016 May; 34(5):993-1004. PubMed ID: 26886567
[TBL] [Abstract][Full Text] [Related]
18. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
Khokhlova ON; Murashev AN; Medvedev OS
Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of central I1 imidazoline receptor in ethanol counteraction of clonidine hypotension in spontaneously hypertensive rats.
El-Mas MM; Abdel-Rahman AA
J Cardiovasc Pharmacol; 2001 Sep; 38(3):417-26. PubMed ID: 11486246
[TBL] [Abstract][Full Text] [Related]
20. Role of I1-imidazoline receptors within the caudal ventrolateral medulla in cardiovascular responses to clonidine in rats.
Wang WZ; Yuan WJ; Ren AJ; Pan YX; Tang CS; Su DF
J Cardiovasc Pharmacol; 2003 Jul; 42(1):1-9. PubMed ID: 12827019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
